Literature DB >> 1769940

A study of the beta-lactamases of 100 clinical isolates of Yersinia enterocolitica.

J N Pham1, S M Bell, J Y Lanzarone.   

Abstract

The intracellular beta-lactamases of 100 distinct clinical isolates of Yersinia enterocolitica were examined, to investigate the effect of selected beta-lactam agents on the enzymes. The enzyme inhibition profiles obtained were specific to each of the three biotypes 1A, 3 and 4. Biotype 4 strains elaborated only one beta-lactamase with a pI of 8.3 corresponding to the carbenicillin-hydrolysing beta-lactamase enzyme A of Cornelis & Abraham. Biotype 3 strains also produced a single beta-lactamase with a pI of 5.4-5.6 corresponding to enzyme B, the chromosomally mediated inducible cephalosporinase. Two beta-lactamases were found in biotype 1A strains, one was identical to enzyme A and the other, although showing a slight difference in pI to enzyme B, was similar to this enzyme in other respects. The differences in the distribution of enzyme A and enzyme B in strains of Y. enterocolitica belonging to the biotypes 1A, 3 and 4 isolated in Australia, explain the different patterns of susceptibility to beta-lactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769940     DOI: 10.1093/jac/28.1.19

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Characterisation of atypical biotype 3, serotype O:3 Yersinia and development of a simple identification scheme.

Authors:  J N Pham; S M Bell; I Guilvout; L Martin; E Carniel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

2.  Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona.

Authors:  G Prats; B Mirelis; T Llovet; C Muñoz; E Miró; F Navarro
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Contribution of BlaA and BlaB beta-lactamases to antibiotic susceptibility of Yersinia enterocolitica biovar 1B.

Authors:  Zachary W Bent; Glenn M Young
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  A 5-year study of the bacterial pathogens associated with acute diarrhoea on the island of Crete, Greece, and their resistance to antibiotics.

Authors:  S Maraki; A Georgiladakis; Y Tselentis; G Samonis
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

5.  Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990.

Authors:  M A Preston; S Brown; A A Borczyk; G Riley; C Krishnan
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Molecular Characterization of Multidrug-Resistant Yersinia enterocolitica From Foodborne Outbreaks in Sweden.

Authors:  Philip A Karlsson; Eva Tano; Cecilia Jernberg; Rachel A Hickman; Lionel Guy; Josef D Järhult; Helen Wang
Journal:  Front Microbiol       Date:  2021-05-13       Impact factor: 5.640

7.  Multilocus variable-number tandem-repeat analysis, pulsed-field gel electrophoresis, and antimicrobial susceptibility patterns in discrimination of sporadic and outbreak-related strains of Yersinia enterocolitica.

Authors:  Leila M Sihvonen; Susanna Toivonen; Kaisa Haukka; Markku Kuusi; Mikael Skurnik; Anja Siitonen
Journal:  BMC Microbiol       Date:  2011-02-25       Impact factor: 3.605

8.  Characteristics of beta-lactamases and their genes (blaA and blaB) in Yersinia intermedia and Y. frederiksenii.

Authors:  Shilpi Mittal; Sarita Mallik; Sachin Sharma; Jugsharan S Virdi
Journal:  BMC Microbiol       Date:  2007-04-03       Impact factor: 3.605

9.  Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.

Authors:  Neelja Singhal; Abhishikha Srivastava; Manish Kumar; Jugsharan Singh Virdi
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.